Abstract TP31: Identifying Multivariate Nonlinear Bias in Sammpris Using Graph-Based AI Analysis

Fabien Scalzo,David S Liebeskind,Jason D Hinman,Aleena Seyedzadeh
DOI: https://doi.org/10.1161/str.55.suppl_1.tp31
IF: 10.17
2024-02-01
Stroke
Abstract:Background: Clinical trials are the most rigorous way of testing how novel treatments compare with existing ones regarding outcomes. The randomized controlled clinical trial has become the standard means of providing proof of safety and effectiveness across the board in medicine, including stroke. Yet, the risk factors among patients that are randomized might not always be equally distributed such that a bias may occur. In this study, we focus on the SAMMPRIS clinical trial aimed to assess the safety and efficacy of aggressive medical management versus stenting for preventing recurrent stroke in patients with symptomatic intracranial arterial stenosis. Methods: We developed and evaluated a machine learning model to identify potential multivariate bias present in the dataset that could not have been identified using standard statistical tests. Our approach utilizes a machine learning model based on the spectral regression model (SR-KDA) to identify biases created by combinations of variables. SR-KDA is based on a graph representation of the data that is processed via discriminative analysis to identify groups of patients that share common characteristics. By using both the treatment and outcome variables as constraints, the model is able to identify nonlinear relationships between clinical variables and the outcome. It can also be used to identify bias as part of the randomization that could have inadvertently skewed the statistical results with standard methodologies. Results: Our approach was successfully applied to the SAMMPRIS clinical dataset, which includes 121 clinical variables. The algorithm was able to automatically identify 6 clusters of patients that had a different response to treatment when considering the clinical variables. Each group was then assigned a set of the variables' cut-off values that best describe them. Conclusion: We have developed a sophisticated system that is capable of detecting non-linear correlations in clinical data collected during trials. This solution has the potential to mitigate any biases that may arise during the randomization process, which could ultimately improve recruitment efforts. Moving forward, this innovative tool could be applied proactively to future clinical trials.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?